SEATTLE – February 17, 2026 – Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein-Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is ...

Creative Biolabs today announced the upgrade of its next-generation drug discovery pipeline with integrated AI-driven ...

BEIJING & PRAGUE--(BUSINESS WIRE)--Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human ...

“Brian brings a proven track record of translating cutting-edge technologies into widely adopted platforms,” said Malek Fahem, Chief Scientist at Illumina Ventures. “His leadership will be ...

New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...

Antibody humanization involves modifying antibodies from non-human sources, such as mice, to decrease their immunogenicity in human applications. While mouse monoclonal antibodies are specific, they ...

Scientists have identified human antibodies capable of targeting the proteins responsible for severe malaria, potentially paving the way for new vaccines or treatments. Using organ-on-a-chip ...

The global resurgence of mpox, along with its evolving epidemiology and sustained human-to-human transmission, highlights the need to investigate the human antibody response to key monkeypox virus ...

Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies ...

Malaria, particularly in its severe forms, remains a global health and economic burden. It causes the deaths of more than 600,000 people every year – most of them African children under five. In a new ...